[go: up one dir, main page]

GB201917908D0 - Novel treatments - Google Patents

Novel treatments

Info

Publication number
GB201917908D0
GB201917908D0 GBGB1917908.4A GB201917908A GB201917908D0 GB 201917908 D0 GB201917908 D0 GB 201917908D0 GB 201917908 A GB201917908 A GB 201917908A GB 201917908 D0 GB201917908 D0 GB 201917908D0
Authority
GB
United Kingdom
Prior art keywords
novel treatments
treatments
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1917908.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncopeptides AB
Original Assignee
Oncopeptides AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncopeptides AB filed Critical Oncopeptides AB
Priority to GBGB1917908.4A priority Critical patent/GB201917908D0/en
Publication of GB201917908D0 publication Critical patent/GB201917908D0/en
Priority to CN202080033269.3A priority patent/CN114025753A/en
Priority to PCT/EP2020/059641 priority patent/WO2020201542A1/en
Priority to JP2021558941A priority patent/JP2022527532A/en
Priority to US17/600,657 priority patent/US12396975B2/en
Priority to EP20717171.1A priority patent/EP3946309A1/en
Ceased legal-status Critical Current

Links

GBGB1917908.4A 2019-04-03 2019-12-06 Novel treatments Ceased GB201917908D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1917908.4A GB201917908D0 (en) 2019-12-06 2019-12-06 Novel treatments
CN202080033269.3A CN114025753A (en) 2019-04-03 2020-04-03 Treatment of AL amyloidosis with meflufen
PCT/EP2020/059641 WO2020201542A1 (en) 2019-04-03 2020-04-03 Treatment of al amyloidosis with melflufen
JP2021558941A JP2022527532A (en) 2019-04-03 2020-04-03 Treatment of AL amyloidosis with melflufen
US17/600,657 US12396975B2 (en) 2019-04-03 2020-04-03 Treatment of al amyloidosis with melflufen
EP20717171.1A EP3946309A1 (en) 2019-04-03 2020-04-03 Treatment of al amyloidosis with melflufen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1917908.4A GB201917908D0 (en) 2019-12-06 2019-12-06 Novel treatments

Publications (1)

Publication Number Publication Date
GB201917908D0 true GB201917908D0 (en) 2020-01-22

Family

ID=69172032

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1917908.4A Ceased GB201917908D0 (en) 2019-04-03 2019-12-06 Novel treatments

Country Status (1)

Country Link
GB (1) GB201917908D0 (en)

Similar Documents

Publication Publication Date Title
GB201800274D0 (en) Novel treatments
GB201916237D0 (en) Novel treatment
GB201900702D0 (en) Therapy
ZA202006321B (en) Treatments
GB201701315D0 (en) Novel treatments
GB201808564D0 (en) Treatments
GB202006390D0 (en) Novel treatments
GB201913988D0 (en) Novel treatment
GB201914296D0 (en) Treatment
GB201912365D0 (en) Treatment
IL288526A (en) Thiarabine- and thiarabine prodrug-based treatments
GB201917908D0 (en) Novel treatments
GB201913636D0 (en) Novel treatments
GB201904714D0 (en) Novel treatments
GB202109894D0 (en) Novel treatments
GB201916754D0 (en) Novel treatment
GB201916239D0 (en) Novel treatment
GB201916238D0 (en) Novel treatment
GB201916234D0 (en) Novel treatment
GB201916235D0 (en) Novel treatment
GB201916236D0 (en) Novel treatment
GB202101292D0 (en) Novel treatments
GB202101291D0 (en) Novel treatments
GB202017858D0 (en) Novel treatments
GB201801982D0 (en) Novel treatments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)